Price Data Unavailable
Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforethey may transform into cancer. The Company'sdisruptivecapsule-basedscreening technology aims to significantly increasescreening adherenceworldwide and help millions of people tostay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.
WallstreetBets Trending Stocks (24h)